The complex network of interactive mechanisms among dapagliflozin treatment, insulin dose titration, plasma glucose concentrations, and HbA1c levels in patients with T1D substantiates the need for further mechanistic model-based analyses. The gene discussed is INS; the disease is type 1 diabetes mellitus.